Novartis opens new pharmaceutical plant and intends to build biotech facility in Singapore
Novartis also expects to invest USD 700 million to build large-scale biotechnology facility in Singapore to support the company's growing pipeline of biopharmaceuticals
31-Oct-2007 -
The Singapore Economic Development Board anoounced that Novartis officially inaugurated a new state-of-the-art pharmaceutical manufacturing site in Tuas, Singapore, adding capacity to its global production network to meet business growth and support new product launches in the US and Japanese ...
biologics
biopharmaceuticals
biotechnology
+4